autologous tumor cell vaccine
autologous tumor cell vaccine is a biological therapy with 23 clinical trials. Historical success rate of 68.4%.
Success Metrics
Based on 13 completed trials
Phase Distribution
Phase Distribution
9
Early Stage
14
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
65.0%
13 of 20 finished
35.0%
7 ended early
0
trials recruiting
23
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Vaccine Therapy in Treating Patients With Multiple Myeloma
Vaccine Therapy Following Chemotherapy & Peripheral Stem Cell Transplantation in Treating Non-Hodgkin's Lymphoma
DC Vaccine Combined With IL-2 and IFNα-2a in Treating Patients With mRCC
Vaccine Therapy Compared With Interferon Alfa in Treating Patients With Stage III Melanoma
Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III, Stage IV, or Recurrent Follicular Lymphoma
Clinical Trials (23)
Vaccine Therapy in Treating Patients With Multiple Myeloma
Vaccine Therapy Following Chemotherapy & Peripheral Stem Cell Transplantation in Treating Non-Hodgkin's Lymphoma
DC Vaccine Combined With IL-2 and IFNα-2a in Treating Patients With mRCC
Vaccine Therapy Compared With Interferon Alfa in Treating Patients With Stage III Melanoma
Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III, Stage IV, or Recurrent Follicular Lymphoma
Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma
Vaccine Therapy Following Therapeutic Autologous Lymphocytes and Cyclophosphamide in Treating Patients With Metastatic Melanoma
Vaccine Therapy With or Without Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Multiple Myeloma Undergoing Donor Stem Cell Transplant
Vaccine Therapy and GM-CSF in Treating Patients With Recurrent or Metastatic Melanoma
Vaccine Therapy With or Without Fludarabine in Treating Patients With Stage IV Kidney Cancer
Biological Therapy in Treating Patients With Glioblastoma Multiforme
Vaccine Therapy in Treating Patients With Stage IV Melanoma
Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer
Vaccine Therapy in Treating Patients With Stage II or Stage III Colon Cancer That Has Been Removed During Surgery
Vaccine Therapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer
Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer
Biological Therapy Following Surgery in Treating Patients With Stage III or Stage IV Melanoma
Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma
Vaccine Therapy in Treating Patients With Acute Myeloid Leukemia
Cyclophosphamide and Rituximab Followed By Vaccine Therapy in Treating Patients With Chronic Lymphocytic Leukemia
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 23